June 2, 2017 / 12:07 PM / 6 months ago

BRIEF-Mylan launches generic Azilect tablets

June 2 (Reuters) - Mylan NV:

* Mylan launches generic Azilect® tablets

* Mylan NV - ‍u.s. Launch of rasagiline tablets, 0.5 mg and 1 mg, a generic version of reference listed drug, Teva’s azilect tablets​

* Mylan NV - received final approval from u.s. Food and drug administration (FDA) for its abbreviated new drug application (ANDA) for rasagiline tablets Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below